Tarsus Pharmaceuticals
The Director, Early Development - Clinical Sciences will lead the creation of early development clinical plans, program outlines, study designs, and essential clinical documents. This role oversees cross‑functional study teams, collaborates with multiple functions such as Clinical Operations, Regulatory Affairs, and Medical Affairs, and ensures scientific rigor and operational excellence in early‑stage clinical programs.
Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with high unmet need, with a primary focus on eye care. The company markets XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis, and has a pipeline targeting conditions such as ocular rosacea and Lyme disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tarsus Pharmaceuticals.
10% above the average for this role
Senior Manager, Clinical Sciences
Regeneron Pharmaceuticals
Clinical Development Medical Director-Nephrology
lifelancer
Senior Director, Clinical Science
CytomX Therapeutics
Clinical Development Associate Medical Director
Vertex
Senior Clinical Scientist
Arcus Biosciences
Senior Director, Clinical Sciences
Tango Therapeutics